Recently, serum FGF21 levels were associated with diastolic cardiac dysfunction in humans with cardiovascular diseases, such as dyslipidemic patients with coronary artery disease (50), but only a few reports have examined FGF21's role in heart failure (88). This evidence concerns the gene FGF21 and heart failure.